期刊文献+

巨细胞病毒特异性IgG抗体检测方法的建立及应用 被引量:3

Establishment and application of novel method for detecting specific cytomegalovirus IgG antibody
下载PDF
导出
摘要 目的为了建立一种快速、简便、实用的可用于育龄妇女血清中巨细胞病毒(CMV)-IgG抗体的筛查方法,并初步探索其应用价值。方法建立重组CMV(pp150+52)抗原;以国家人口和计划生育委员会科学技术研究所(简称本所)建立的重组CMV(pp150+52)抗原作为包被抗原,700IU/L作为临界值,用间接ELISA方法,对深圳宝安区1024例血清标本进行CMV-IgG抗体的检测。结果该方法灵敏度为13IU/L,批内变异系数4.7%~7.0%,批间变异系数7.6%~14.4%,并与SORIN公司生产的试剂盒进行了比较,2种方法呈最度相关,Kappa值为0.82;深圳宝安区1024例血清标本CMV-IgG抗体阳性率为93.3%(955/1024),阴性率为6.7%(69/1024)。结论本所建立的ELISA方法快速、简便和实用,可用于育龄妇女CMV-IgG抗体的筛查。 Objective To establish a rapid, serum and convenient method for the screening of cytomegalovirus (CMV) specific IgG antibody in sera samples of women of childbearing age, and to evaluate the preliminary significance of application. Methods The measurement of CMV-IgG was conducted by indirect enzyme linked immunosorbent assay using recombinant CMV-Ag (pp150 + 52) as coating antigen, and 700 IU/L as Cut-off value. Results The specific CMV-IgG antibodies in sera were detected in 1 024 women of childbearing age in Shenzhen, by using the method established by our study and the ELISA assay kid provided by Diasorin Co. The positive rate, negative rate, sensitivity of our method was 93. 3 %, 6. 7 %, and 13 IU/L, respectively. The intraassay coefficient of variation was between 4. 7 % -7.0 % and the interassay coefficient of variation was between 7.6% - 14. 4 %. The Kappa value between our method and ELISA assay kid provided by Diasorin Co. was 0. 82, indicating a good relativity. Conclusion Our ELISA assay is a rapid, easy and convenient method and could be used for screening the CMV -IgG specific antibodies among premarital women.
出处 《中国生育健康杂志》 2009年第3期154-157,共4页 Chinese Journal of Reproductive Health
基金 国家"十一五"科技支撑计划项目课题(2006BAI05A02)
关键词 巨细胞病毒 IGG抗体 ELISA 筛查 育龄妇女 Cytomegalovirus IgG antibody ELISA Screening Women of childbearing age
  • 相关文献

参考文献9

  • 1Kenneson A,Cannon MJ.Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection[J].Rev Med Virol,2007,17 (4):253-276.
  • 2Omoy A,Diav-citrin O.Fetal effects of primary and secondary cytomegalovirus infection in pregnancy[J].Reproductive Toxicology,2006,21:399-409.
  • 3Adler SP,Nigro G,Pereira L Recent advances in the prevention and treatment of congenital cytomegalovirus infections[J].Semin Perinatol,2007,31 (1):10-18.
  • 4Fowler KB,Stagno S,Pass RF.Maternal immunity and prevention of congenital cytomegalovirus infection[J].JAMA,2003,289(8):1008-1011.
  • 5Booth JC,Hannington G,Aziz TA,et al.Comparison of enzymelinked immunosorbant assay (ELISA) technique and complementfixation test for estimation of cytomegalovirus IgG antibody[J].J Clin Pathol,1979,32 (2):122-127.
  • 6Weber B,Berger A,Rabenau H.Human cytomegalovirus infection:diagnostic potential of recombinant antigens for cytomegalovirus antibody detection[J].J Virol Methods,2001,96 (2):157-70.
  • 7Guangeot-Keros L,Cointe D.Diagnosis and prognostic markers of HCMV infection[J].J Clin Virol,2001,21 (3):213-221.
  • 8孙立山,周文达.人巨细胞病毒感染的实验室诊断研究进展[J].检验医学,2005,20(3):284-286. 被引量:7
  • 9Landini MP,Lazzarotto T,Maine GT,et al.Recombinant monoand polyantigens to detect cytomegalovirus-specific immunoglobulin M in human sera by enzyme inmnmoassay[J].J Clin Microbiol,1995,33 (10):2535-2542.

二级参考文献15

  • 1Blank BS, Meenhorst PL, Pauw W, et al. Detection of late pp67-mRNA by NASBA in peripheral blood for the diagnosis of Human cytomegalovirus disease in AIDS patients[J]. J Clin Viro1,2002,25:29-38.
  • 2Witt DJ, Kemper M, Stead A, et al. Analytical performance and clinical utility of a nucleic acid sequence-based amplification assay for detection of Cytomegalovirus infection [J]. J Clin Microbiol, 2000,38 : 3994-3999.
  • 3Revello MG, Lilleri D, Zavattoni M, et al. Prenatal diagnosis of congenital Human cytomegalovirus infection in amniotic fluid by nucleic acid sequence-based amplification assay [J]. J Clin Microbio1,2003,41:1772-1774.
  • 4Greijer AE, Verschuuren EA, Harmsen MC, et al.Direct quantification of Human cytomegalovirus immediate-early and late mRNA levels in blood of lung transplant recipients by competitive nucleic acid sequence-based amplification [J]. J Clin Microbio1,2001,39 :251-259.
  • 5Maine GT, Stricker R, Schuler M, et al. Development and clinical evaluation of a recombinant-antigen-based cytomegalovirus immunoglobulin M automated immunoassay using the Abbott AxSYM analyzer [J]. J Clin Microbiol, 2000,38 : 1476-1481.
  • 6Eggers M, Radsak K, Enders G, et al. Use of recombinant glycoprotein antigens gB and gH for diagnosis of primary Human cytomegalovirus infection during pregnancy [J]. J Med Viro1,2001,63 : 135-142.
  • 7Greijer AE, Van De Crommert JM, Stevens SJ, et al. Molecular fine-specificity analysis of antibody responses to Human cytomegalovirus and design of novel synthetic-peptide-based serodiagnositic assays [J]. J Clin Microbiol, 1999,37: 179-188.
  • 8Bodeus M, Goubau P. Predictive value of maternal-lgG avidity for congenital Human cytomegalovirus infection [J]. J Clin Virol, 1999,12:3-8.
  • 9Lazzarotto T, Galli C, Pulvirenti R, et al. Evaluation of the Abbott AxSYM Cytomegalovirus ( CMV ) immunoglobulin M (IgM) assay in conjunction with other CMV IgM tests and a CMV IgG avidity assay [J]. Clin Diagn Lab Immuno1,2001 ,8:196-198.
  • 10Eggers M, Metzger C, Enders G. Differentiation between acute primary and recurrent Human cytomegalovirus infection in pregnancy, using a microneutralization assay[J]. J Med Virol,1998,56:351-358.

共引文献6

同被引文献38

  • 1孙立山,周文达.人巨细胞病毒感染的实验室诊断研究进展[J].检验医学,2005,20(3):284-286. 被引量:7
  • 2王敏,毛建平.人巨细胞病毒检测技术[J].中国生物工程杂志,2007,27(2):103-107. 被引量:7
  • 3中华医学会儿科学分会感染消化学组.巨细胞病毒感染诊断方案.中国实用儿科杂志,2000,15(2):121-121.
  • 4Adler SP, Nigro G, Pereira L. Recent advances in the prevention and treatment of congenital cytomegalovirus infections [J]. Semin Perinatol, 2007, 31 (1): 10-18.
  • 5Zhong J, Rist M, Cooper L, et ol. Induction of pluripotent pro- tective immunity following immunisation with a chimeric vaccine against human cytomegalovirus [J]. PLoS One, 2008, 3 (9): e3256-e3278.
  • 6Akinbami AA, Rabiu KA, Adewunmi AA, et al. Seroprevalence of cytomegalovirus antibodies amongst normal pregnant women in Nigeria [J]. Int J Womens Health, 2011, 3(1) : 423-428.
  • 7Centers for Disease Control and Prevention (CDC). Cytomega lovirus (CMV) and Congenital CMV infection [EB/OL]. (2010- 07-28) [2011-06-23 ]. http://www, ede.gov /cnav / elinieal / lab- tests.html.
  • 8Bonaros K, Mayer B, Schachner T, et al. CMV-hyperimmune globulin for preventing cytomegalovims infection and disease in solid organ transplant recipients: a meta-analysis [J]. Clin Trans- plant, 2008, 22 ( 1 ) : 89-97.
  • 9Zamora MR, Nicolls MR, Hodges TN, et aL Following universal prophylaxis with intravenous ganciclovir and cytomegalovirus im- mune globulin, valganciclovir is safe and effective for prevention of CMV infection following lung transplantation [J]. Am J Trans- plant, 2004, 4 (10): 1635-1642.
  • 10Snydman DR, Wemer BG, Heinze-Lacey B, et al. Use of cy- tomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients [J]. N Engl J Med, 1957, 317 (17) : 1049-1054.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部